BUILD Study
Not Applicable
- Conditions
- gastric cancer, breast cancer
- Registration Number
- JPRN-jRCT1031230453
- Lead Sponsor
- Yasunaga Masahiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1) Patients with breast or gastric cancer who are scheduled to start or have started their first T-DXd treatment in January 2022 or later.
2) Written consent for this study has been obtained from the patient.
Exclusion Criteria
1) Patients with a history of interstitial lung disease or undeniable on pre-enrollment testing
2) Patients participating in a clinical trial
3) Patients who are deemed inappropriate by the principal investigator or sub investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of ILD
- Secondary Outcome Measures
Name Time Method